Uojima, H., Chuma, M., Tanaka, Y., Hidaka, H., Nakazawa, T., Iwabuchi, S., . . . Koizumi, W. (2020). Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib. Liver Cancer.
Chicago Stili AlıntıUojima, Haruki, et al. "Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated With Lenvatinib." Liver Cancer 2020.
MLA AlıntıUojima, Haruki, et al. "Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated With Lenvatinib." Liver Cancer 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..